Literature DB >> 12576862

Continent urinary diversion and the exstrophy-epispadias complex.

Ilhami Surer1, Fernando A Ferrer, Linda A Baker, John P Gearhart.   

Abstract

PURPOSE: The use of continent urinary reservoirs has gained wide acceptance, particularly in urinary reconstruction in children with a small capacity or neuropathic bladder. When augmentation cystoplasty is combined with clean intermittent catheterization, patients are often able to achieve continence with low intravesical filling pressures and renal preservation. Often this approach requires fashioning a continent cutaneous stoma, which remains the most challenging aspect of continent urinary reservoirs. We analyzed our experience with continent diversion in patients with exstrophy-epispadias to determine complications and long-term results.
MATERIALS AND METHODS: We performed a retrospective database review of 704 cases of exstrophy-epispadias. Medical records were then used to identify those patients who had undergone creation of a continent urinary reservoir. Charts were reviewed to determine initial diagnosis, augmentation technique, continence mechanism, age, preoperative and postoperative bladder capacity, continence status and complications.
RESULTS: Of the 91 patients identified (68 male, 23 female) who had undergone continent urinary diversion classic bladder exstrophy was present in 80, cloacal exstrophy in 8, complete male epispadias in 2 and female epispadias in 1. The most common techniques for augmentation and continent diversion were ileocystoplasty (41 patients [45%]) and sigmoid cystoplasty (30 [33%]), respectively. Appendix was used in 67 patients (74%) and variants of the Mitrofanoff procedure using segments of tapered ileum or ureter were used to create a continent stoma in 10 (11%). Bladder neck transection was performed in 59 patients (65%). Mean age at augmentation and continent diversion was 8 years (range 2 to 25), with a mean preoperative bladder capacity of 77 cc (15 to 220). Mean followup was 6 years (range 6 months to 12 years). Of the 91 patients 85 (93%) were continent with clean intermittent catheterization per stoma. Of these 85 patients 13 required anticholinergics and alpha-agonists to achieve continence. Six patients (7%) were incontinent after the procedure. Analysis of bladder capacity measurements after augmentation and continent diversion revealed that mean postoperative volume and mean volume increase were 404 cc (range 250 to 640) and 524%, respectively. The most common complications were bladder stone formation (24 patients [26%]) and stomal stenosis (21 [23%]). Bladder stones recurred in 9 patients and stomal stenosis in 3. Other less common complications were vesicourethral fistula (3 patients) and a small bladder perforation (2).
CONCLUSION: Augmentation and continent diversion procedures can increase the functional capacity of the small contracted noncompliant exstrophic bladder, and allow the vast majority of patients to achieve continence and preserve renal function. Bladder calculi and stomal stenosis pose the most significant long-term complications in these patients.

Entities:  

Mesh:

Year:  2003        PMID: 12576862     DOI: 10.1097/01.ju.0000044921.19074.d0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Reconstruction of bladder and urethra using ileocecal segment and appendix in patients with exstrophy-epispadias complex: the first report of a new surgical approach.

Authors:  Mohammad Ali Amirzargar; Mahnaz Yavangi; Manouchehr Ghorbanpour; Seyed Mohammadmehdi Hosseini Moghaddam; Mohammad Rahnavardi; Nasibeh Amirzargar
Journal:  Int Urol Nephrol       Date:  2006-12-14       Impact factor: 2.370

2.  The perioperative and convalescence nursing of 5 cases of Monti ileovesicostomy.

Authors:  Li Ma; Ling Liu; Hong Shen; Dan Dan; Li Wang; Yu-Han Deng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 3.  Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA.

Authors:  Evan Shreck; Kevin Gioia; Alvaro Lucioni
Journal:  Curr Urol Rep       Date:  2016-04       Impact factor: 3.092

Review 4.  Modern management of bladder exstrophy repair.

Authors:  Brian M Inouye; Eric Z Massanyi; Heather Di Carlo; Bhavik B Shah; John P Gearhart
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

5.  Comparing the bulking effect of calcium hydroxyapatite and Deflux injection into the bladder neck for improvement of urinary incontinence in bladder exstrophy-epispadias complex.

Authors:  Sahar Eftekharzadeh; Nastaran Sabetkish; Shabnam Sabetkish; Abdol-Mohammad Kajbafzadeh
Journal:  Int Urol Nephrol       Date:  2016-11-28       Impact factor: 2.370

Review 6.  Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle.

Authors:  Olivier Boyer; Gillian Butler-Browne; Hector Chinoy; Giulio Cossu; Francesco Galli; James B Lilleker; Alessandro Magli; Vincent Mouly; Rita C R Perlingeiro; Stefano C Previtali; Maurilio Sampaolesi; Hubert Smeets; Verena Schoewel-Wolf; Simone Spuler; Yvan Torrente; Florence Van Tienen
Journal:  Front Genet       Date:  2021-08-02       Impact factor: 4.599

7.  Sub-urothelial polyp enucleation resection and urothelial auto-augmentation cystoplasty: a simple method for bladder exstrophy-epispadias complex reconstruction in bladder plate polyposis.

Authors:  Abdol-Mohammad Kajbafzadeh; Ali Tourchi; Nastaran Sabetkish
Journal:  Pediatr Surg Int       Date:  2014-05-07       Impact factor: 1.827

Review 8.  Current management of bladder exstrophy.

Authors:  Arthur Mourtzinos; Joseph G Borer
Journal:  Curr Urol Rep       Date:  2004-04       Impact factor: 2.862

9.  Bladder augmentation and continent urinary diversion in boys with posterior urethral valves.

Authors:  Małgorzata Baka-Ostrowska
Journal:  Cent European J Urol       Date:  2011-12-09

10.  Augmentation cystoplasty: Contemporary indications, techniques and complications.

Authors:  Rajan Veeratterapillay; Andrew C Thorpe; Chris Harding
Journal:  Indian J Urol       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.